Newstral
Article
Hhamodia.com on 2020-05-18 14:48
Teva Gets China Approval for Huntington’s Treatment
Related news
- Israel’s Teva gets China’s green light for Huntington’s treatmenttimesofisrael.com
- After Delays, Teva Wins Approval From U.S. for Migraine TreatmentHaaretz
- MAstraZeneca's asthma treatment gets China approvalmarketwatch.com
- Analysis Teva Pharmaceuticals Gets a Coronavirus Boost, but It Won’t Last LongHaaretz
- Bayer acquisition of Monsanto gets conditional approval from ChinaThe Globe and Mail
- Teva gets FDA approval for 1st generic nasal spray of overdose reversal drugtimesofisrael.com
- Raleigh's Merz gets FDA approval for Botox-competing treatmentbizjournals.com
- HAmid Crisis, Teva Gets a New Sefer Torahhamodia.com
- FUS grants first approval for China cancer treatmentft.com
- HTeva Gets OK on Migraine Drug, Share Price Surgeshamodia.com
- Teva Shares Rally, Forecast 'Very Strong Launch' for Long-awaited Ajovy Migraine TreatmentHaaretz
- FDA Approval of Alvotech/Teva Ustekinumab Biosimilarjdsupra.com
- Trump gets initial approval for 38 new trademarks — in ChinaCBC
- Disney gets approval from China for Fox purchaseCNN
- China Huarong Asset Management Gets Approval for $3 Billion IPOwsj.com
- GSK gets approval for Shingles vaccine in Chinabizjournals.com
- China Gets Its First mRNA Vaccine Approval — in IndonesiaThe New York Times
- China Billionaire Lighting Couple's Opple Gets IPO ApprovalForbes
- MWhy Teva stock isn’t moving on its major Huntington’s disease drug approvalmarketwatch.com